Figure 4From: The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?Inclusion criterion for the retrospective analysis of 47 L76V-positive patients.Back to article page